Our knowledge about the age-related growth of pulmonary function is incompl
ete. The purpose of this study was to describe the relation of various fact
ors to the growth of pulmonary function in children and adolescents. A popu
lation sample comprising 408 children and adolescents (7-17 yr of age at en
rollment) was reexamined after a 6-yr interval. Case history was obtained b
y interview and questionnaire. Pulmonary function, skin prick test reactivi
ty to common allergens, and airway responsiveness (AR) were measured using
standard techniques; airway hyperresponsiveness (AHR) was defined as a conc
entration of histamine causing a 20% decline in FEV1 < 8 mg/ml. The cross-s
ectional analyses of data from the two surveys showed that the presence of
asthma (p < 0.02), atopy to house dust mite (HDM) (p = 0.03), and increasin
g degree of AR (p < 0.002) were associated with a lower level of FEV1 %pred
. The longitudinal analysis revealed that asthma (p = 0.0001) and a lower l
evel of FEV1 (p < 0.0001) at enrollment were associated with a lower level
of FEV1 at follow-up. Further, an increase in the degree of AR (p = 0.0001)
, new asthma (p = 0.0002), and new atopy to HDM (p = 0.03) also predicted a
lower level of FEV1 at the end of the observation period. Confining the an
alysis to subjects without asthma and without evidence of AHR (n = 271) sho
wed that both persistent (p = 0.04) and new (p = 0.03) atopy to HDM predict
ed a lower level of FEV1 at follow-up; compared with subjects with a negati
ve skin reaction to HDM, those subjects who were sensitized to HDM had on a
verage a 5%pred lower level of FEV1. The growth of FEV1 in children and ado
lescents appears to be impaired not only by symptomatic asthma but also by
an increase in the degree of AR and atopy to HDM; sensitization to HDM appe
ars to have a negative impact on the age-related growth in FEV1 even in non
asthmatic subjects without evidence of AHR.